Promotions & Moves

PAREXEL Names New CEO

Josef von Rickenbach, who co-founded the company, will retire

By: Kristin Brooks

Managing Editor, Contract Pharma

Jamie Macdonald has been appointed chief executive officer of PAREXEL effective March 15, 2018. Josef von Rickenbach, who co-founded the company, will retire and continue as chairman of the board.

Mr. Macdonald led INC Research, now Syneos Health, for several years first as chief executive officer and most recently as vice chairman. Under his leadership, INC Research achieved strong operational and market performance, and undertook a successful Initial Public Offering (IPO) in 2014. Prior to this, he served as INC’s chief operating officer. In addition, Mr. Macdonald has held several leadership positions in the biopharmaceutical services industry, including senior vice president and head of Global Project Management at Quintiles, now known as IQVIA.

Mr. von Rickenbach co-founded PAREXEL in 1982 and has since served as chairman and chief executive officer, building the company to a valuation of over five billion dollars with operations in more than 100 countries.

“When we started PAREXEL more than 35 years ago, not only was it the beginning of a new company, it was also the dawn of a new industry,” said Mr. von Rickenbach.  “Today, a new era begins. The biopharmaceutical services industry is more dynamic and exciting than ever, and Jamie is the right leader to take PAREXEL into the future. I am confident that our next generation will be an even greater one and I am delighted to have him join the Company. I look forward to working with Jamie to continue PAREXEL’s leadership in the marketplace.” <!– /* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:1; mso-generic-font-family:roman; mso-font-format:other; mso-font-pitch:variable; mso-font-signature:0 0 0 0 0 0;} @font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-536870145 1073786111 1 0 415 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0in; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;} p {mso-style-noshow:yes; mso-style-priority:99; mso-margin-top-alt:auto; margin-right:0in; mso-margin-bottom-alt:auto; margin-left:0in; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin;} .MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;} @page WordSection1 {size:8.5in 11.0in; margin:1.0in 1.0in 1.0in 1.0in; mso-header-margin:.5in; mso-footer-margin:.5in; mso-paper-source:0;} div.WordSection1 {page:WordSection1;} — <!–{cke_protected}{C}%3C!%2D%2D%0A%20%2F*%20Font%20Definitions%20*%2F%0A%40font-face%0A%09%7Bfont-family%3A%22Cambria%20Math%22%3B%0A%09panose-1%3A2%204%205%203%205%204%206%203%202%204%3B%0A%09mso-font-charset%3A1%3B%0A%09mso-generic-font-family%3Aroman%3B%0A%09mso-font-format%3Aother%3B%0A%09mso-font-pitch%3Avariable%3B%0A%09mso-font-signature%3A0%200%200%200%200%200%3B%7D%0A%40font-face%0A%09%7Bfont-family%3ACalibri%3B%0A%09panose-1%3A2%2015%205%202%202%202%204%203%202%204%3B%0A%09mso-font-charset%3A0%3B%0A%09mso-generic-font-family%3Aswiss%3B%0A%09mso-font-pitch%3Avariable%3B%0A%09mso-font-signature%3A-536870145%201073786111%201%200%20415%200%3B%7D%0A%20%2F*%20Style%20Definitions%20*%2F%0Ap.MsoNormal%2C%20li.MsoNormal%2C%20div.MsoNormal%0A%09%7Bmso-style-unhide%3Ano%3B%0A%09mso-style-qformat%3Ayes%3B%0A%09mso-style-parent%3A%22%22%3B%0A%09margin%3A0in%3B%0A%09margin-bottom%3A.0001pt%3B%0A%09mso-pagination%3Awidow-orphan%3B%0A%09font-size%3A12.0pt%3B%0A%09font-family%3A%22Calibri%22%2Csans-serif%3B%0A%09mso-ascii-font-family%3ACalibri%3B%0A%09mso-ascii-theme-font%3Aminor-latin%3B%0A%09mso-fareast-font-family%3ACalibri%3B%0A%09mso-fareast-theme-font%3Aminor-latin%3B%0A%09mso-hansi-font-family%3ACalibri%3B%0A%09mso-hansi-theme-font%3Aminor-latin%3B%0A%09mso-bidi-font-family%3A%22Times%20New%20Roman%22%3B%0A%09mso-bidi-theme-font%3Aminor-bidi%3B%7D%0Ap%0A%09%7Bmso-style-noshow%3Ayes%3B%0A%09mso-style-priority%3A99%3B%0A%09mso-margin-top-alt%3Aauto%3B%0A%09margin-right%3A0in%3B%0A%09mso-margin-bottom-alt%3Aauto%3B%0A%09margin-left%3A0in%3B%0A%09mso-pagination%3Awidow-orphan%3B%0A%09font-size%3A12.0pt%3B%0A%09font-family%3A%22Times%20New%20Roman%22%2Cserif%3B%0A%09mso-fareast-font-family%3ACalibri%3B%0A%09mso-fareast-theme-font%3Aminor-latin%3B%7D%0A.MsoChpDefault%0A%09%7Bmso-style-type%3Aexport-only%3B%0A%09mso-default-props%3Ayes%3B%0A%09font-family%3A%22Calibri%22%2Csans-serif%3B%0A%09mso-ascii-font-family%3ACalibri%3B%0A%09mso-ascii-theme-font%3Aminor-latin%3B%0A%09mso-fareast-font-family%3ACalibri%3B%0A%09mso-fareast-theme-font%3Aminor-latin%3B%0A%09mso-hansi-font-family%3ACalibri%3B%0A%09mso-hansi-theme-font%3Aminor-latin%3B%0A%09mso-bidi-font-family%3A%22Times%20New%20Roman%22%3B%0A%09mso-bidi-theme-font%3Aminor-bidi%3B%7D%0A%40page%20WordSection1%0A%09%7Bsize%3A8.5in%2011.0in%3B%0A%09margin%3A1.0in%201.0in%201.0in%201.0in%3B%0A%09mso-header-margin%3A.5in%3B%0A%09mso-footer-margin%3A.5in%3B%0A%09mso-paper-source%3A0%3B%7D%0Adiv.WordSection1%0A%09%7Bpage%3AWordSection1%3B%7D%0A%2D%2D%3E

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters